Home » Topics » Disease categories and therapies » Immune

Immune
RSS

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Aviron's EBV vaccine completes phase I trial

Aug. 13, 1999

Aquila Biopharmaceuticals receives SBIR grant for CD1 tuberculosis vaccine

Aug. 13, 1999

Viron Therapeutics awarded US patent for use of viral proteins as antiinflammatory agents

Aug. 6, 1999

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

Aug. 5, 1999

SB and Finlay Institute of Cuba enter agreement for bacterial meningitis vaccine

Aug. 3, 1999

Mutual recognition granted to Agrippal; vaccine to be marketed throughout Europe

Aug. 2, 1999

Aviron and Medeva extend FluMist collaboration

Aug. 2, 1999

Cangene product for prevention of hemolytic disease approved in U.K.

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...